CenterStar Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CenterStar Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Hold	–	-$653	–	324
2022 Q4	–	Hold	–	–	–	98
2022 Q3	–	Hold	–	-$463K	–	504
2022 Q2	–	Hold	–	–	–	189
2022 Q1	–	Hold	–	–	–	166
2021 Q4	–	Hold	–	-$833K	–	863
2021 Q3	–	Hold	–	–	–	277
2021 Q2	–	Hold	–	–	–	73

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

CenterStar Asset Management's XBI Position: Q3 2024 in Review

CenterStar Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 3,996 shares — an estimated $370K sold.

CenterStar Asset Management first reported a position in XBI in Q3 2023 and held it in 2 quarters. The position peaked at $2.14M in Q3 2023. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

CenterStar Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
CenterStar Asset Management sold 3,996 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $370K.
CenterStar Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and held it in 2 quarters.
CenterStar Asset Management's State Street SPDR S&P Biotech ETF position peaked at $2.14M in Q3 2023.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on CenterStar Asset Management's 13F filing for Q3 2024, filed 11 Oct 2024.